{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:02:16Z","timestamp":1794434536644,"version":"4.9.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tech Coloproctol"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Implantation of Gatekeeper\u2122 prostheses presents an option for the treatment of passive faecal incontinence (FI). Whilst preliminary results are encouraging, long-term data regarding its sustained benefit are limited. The aim of this study was to assess and evaluate the long-term clinical function and quality of life of patients with passive faecal incontinence who were treated with Gatekeeper\u2122 prostheses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was a single centre, single surgeon retrospective study of prospectively collected clinical data in patients with FI treated between June 2012 and May 2019. Patients with passive FI with symptoms refractory to conservative treatment and endoanal ultrasonography showing intact or disrupted internal anal sphincter were included. Formal clinical and quality of life assessments were carried out using the St. Mark\u2019s Incontinence Score (SMIS) and Faecal Incontinence Quality of Life (FIQoL) questionnaires at baseline, 3\u00a0months, 6\u00a0months, 12\u00a0months and then annually. Endoanal ultrasonography was performed both before and after surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Forty patients (14 males, 26 females) with a median age of 62.5 (range 33\u201380) years were treated with the Gatekeeper\u2122 implant. The majority of patients (87.5%) received six implants. There were no peri or post-operative complications. Prosthesis migration was observed in 12.5% patients. The median follow-up duration was 5\u00a0years (interquartile range (IQR) 3.25\u20136.00\u00a0years). A sustained improvement in median SMIS and FIQoL scores from baseline to follow-up was noted. Significant differences were observed between the median baseline SMIS score and last follow-up score of 16.00 (IQR 15.00\u201316.75) to 7.00 (IQR 5.00\u20138.00) respectively (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), a 56.25% decrease. The overall median FIQoL score showed a significant improvement from 7.95 (IQR 7.13\u20139.48) to 13.15 (IQR 12.00\u201313.98) (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) a 65.40% increase.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Gatekeeper\u2122 implantation is a safe approach to treating passive FI and is minimally invasive, reproducible and has minimal complications. Long-term sustained clinical improvement is achievable beyond 5\u00a0years. Careful patient selection is paramount, as is consistency of technique and follow-up protocol.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10151-022-02630-z","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T04:03:14Z","timestamp":1653019394000},"page":"537-543","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["An evaluation of the long-term effectiveness of Gatekeeper\u2122 intersphincteric implants for passive faecal incontinence"],"prefix":"10.1007","volume":"26","author":[{"given":"S. A. A.","family":"Jabbar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0241-8913","authenticated-orcid":false,"given":"J.","family":"Camilleri-Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"issue":"12","key":"2630_CR1","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1002\/bjs.10298","volume":"103","author":"A Sharma","year":"2016","unstructured":"Sharma A, Yuan L, Marshall RJ, Merrie AEH, Bissett IP (2016) Systematic review of the prevalence of faecal incontinence. Br J Surg 103(12):1589\u20131597","journal-title":"Br J Surg"},{"issue":"9","key":"2630_CR2","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s00384-008-0489-x","volume":"23","author":"H Damon","year":"2008","unstructured":"Damon H, Schott A, Barth X et al (2008) Clinical characteristics and quality of life in a cohort of 621 patients with faecal incontinence. Int J Colorectal Dis 23(9):845\u2013851","journal-title":"Int J Colorectal Dis"},{"issue":"12","key":"2630_CR3","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1097\/DCR.0000000000000514","volume":"58","author":"K Ng","year":"2015","unstructured":"Ng K, Sivakumaran Y, Nassar N, Gladman M (2015) Fecal incontinence: community prevalence and associated factors\u2014a systematic review. Dis Colon Rectum 58(12):1194\u20131209","journal-title":"Dis Colon Rectum"},{"issue":"7","key":"2630_CR4","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/DCR.0000000000000397","volume":"58","author":"IM Paquette","year":"2015","unstructured":"Paquette IM, Varma MG, Kaiser AM, Steele SR, Rafferty JF (2015) The American society of colon and rectal surgeons\u2019 clinical practice guideline for the treatment of fecal incontinence. Dis Colon Rectum 58(7):623\u2013636","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"2630_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1055\/s-0031-1272825","volume":"24","author":"DM Hayden","year":"2011","unstructured":"Hayden DM, Weiss EG (2011) Fecal incontinence: etiology, evaluation, and treatment. Clin Colon Rectal Surg 24(1):64","journal-title":"Clin Colon Rectal Surg"},{"issue":"7608","key":"2630_CR6","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1136\/bmj.39231.633275.AD","volume":"334","author":"C Norton","year":"2007","unstructured":"Norton C, Thomas L, Hill J (2007) NICE guidelines: management of faecal incontinence in adults: summary of NICE guidance. BMJ 334(7608):1370\u20131371","journal-title":"BMJ"},{"issue":"48","key":"2630_CR7","doi-asserted-by":"publisher","first-page":"9216","DOI":"10.3748\/wjg.v19.i48.9216","volume":"19","author":"V Koughnett","year":"2013","unstructured":"Koughnett V, Julie Ann M, Wexner SD (2013) Current management of fecal incontinence: choosing amongst treatment options to optimize outcomes. World J Gastroenterol 19(48):9216\u20139230","journal-title":"World J Gastroenterol"},{"issue":"4","key":"2630_CR8","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00384-015-2128-7","volume":"30","author":"N Cohen-Zubary","year":"2015","unstructured":"Cohen-Zubary N, Gingold-Belfer R, Lambort I et al (2015) Home electrical stimulation for women with fecal incontinence: a preliminary randomized controlled trial. Int J Colorectal Dis 30(4):521\u2013528","journal-title":"Int J Colorectal Dis"},{"issue":"1","key":"2630_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/nau.20803","volume":"29","author":"C Norton","year":"2010","unstructured":"Norton C, Whitehead WE, Bliss DZ, Harari D, Lang J (2010) Management of fecal incontinence in adults. Neurourol Urodyn 29(1):199\u2013206","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"2630_CR10","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1055\/s-0036-1584504","volume":"29","author":"K Bochenska","year":"2016","unstructured":"Bochenska K, Boller A (2016) Fecal incontinence: epidemiology, impact, and treatment. Clin Colon Rectal Surg 29(3):264\u2013270","journal-title":"Clin Colon Rectal Surg"},{"issue":"11","key":"2630_CR11","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1002\/bjs.7699","volume":"98","author":"C Ratto","year":"2011","unstructured":"Ratto C, Parello A, Donisi L et al (2011) Novel bulking agent for faecal incontinence. Br J Surg 98(11):1644\u20131652","journal-title":"Br J Surg"},{"issue":"3","key":"2630_CR12","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/bjs.10050","volume":"103","author":"C Ratto","year":"2016","unstructured":"Ratto C, Buntzen S, Aigner F et al (2016) Multicentre observational study of the gatekeeper\u2122 for faecal incontinence. Br J Surg 103(3):290\u2013299","journal-title":"Br J Surg"},{"issue":"1","key":"2630_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/gut.44.1.77","volume":"44","author":"CJ Vaizey","year":"1999","unstructured":"Vaizey CJ, Carapeti E, Cahill JA, Kamm MA (1999) Prospective comparison of faecal incontinence grading systems. Gut 44(1):77\u201380","journal-title":"Gut"},{"issue":"1","key":"2630_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/BF02237236","volume":"43","author":"T Rockwood","year":"2000","unstructured":"Rockwood T, Church J, Fleshman J et al (2000) Fecal incontinence quality of life scale. Dis Colon Rectum 43(1):9\u201316","journal-title":"Dis Colon Rectum"},{"key":"2630_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.5772\/intechopen.77679","volume-title":"Current topics in faecal incontinence","author":"J Camilleri-Brennan","year":"2020","unstructured":"Camilleri-Brennan J (2020) Anal injectable and implantable bulking agents for faecal incontinence. Current topics in faecal incontinence. IntechOpen, London, pp 81\u201394"},{"issue":"8","key":"2630_CR16","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/nmo.12360","volume":"26","author":"A Mellgren","year":"2014","unstructured":"Mellgren A, Matzel KE, Pollack J, Hull T, Bernstein M, Graf W (2014) Long-term efficacy of NASHA dx injection therapy for treatment of fecal incontinence. Neurogastroenterol Motil 26(8):1087\u20131094","journal-title":"Neurogastroenterol Motil"},{"issue":"4","key":"2630_CR17","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s10151-012-0949-8","volume":"17","author":"J Danielson","year":"2013","unstructured":"Danielson J, Danielson J, Karlbom U et al (2013) Efficacy and quality of life 2 years after treatment for faecal incontinence with injectable bulking agents. Tech Coloproctol 17(4):389\u2013395","journal-title":"Tech Coloproctol"},{"issue":"12","key":"2630_CR18","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/bjs.6745","volume":"96","author":"L Bartlett","year":"2009","unstructured":"Bartlett L, Ho YH (2009) PTQ\u2122 anal implants for the treatment of faecal incontinence. Br J Surg 96(12):1468\u20131475","journal-title":"Br J Surg"},{"issue":"3","key":"2630_CR19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3109\/00365521.2012.758770","volume":"48","author":"T Dehli","year":"2013","unstructured":"Dehli T, Stordahl A, Vatten LJ et al (2013) Sphincter training or anal injections of dextranomer for treatment of anal incontinence: a randomized trial. Scand J Gastroenterol 48(3):302\u2013310","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"2630_CR20","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1463-1318.2008.01634.x","volume":"11","author":"JJ Tjandra","year":"2009","unstructured":"Tjandra JJ, Chan MKY, Yeh HCH (2009) Injectable silicone biomaterial (PTQTM) is more effective than carbon-coated beads (durasphere) in treating passive faecal incontinence a randomized trial. Colorectal Dis 11(4):382\u2013389","journal-title":"Colorectal Dis"},{"issue":"1","key":"2630_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10151-014-1236-7","volume":"19","author":"F Guerra","year":"2015","unstructured":"Guerra F, Guerra F, La Torre M et al (2015) Long-term evaluation of bulking agents for the treatment of fecal incontinence: clinical outcomes and ultrasound evidence. Tech Coloproctol 19(1):23\u201327","journal-title":"Tech Coloproctol"},{"issue":"4","key":"2630_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s13304-012-0176-x","volume":"64","author":"Z Hussain","year":"2012","unstructured":"Hussain Z, Lim M, Mussa H, Abbas K, Stojkovic S (2012) The use of permacol\u00ae injections for the treatment of faecal incontinence. Updates Surg 64(4):289\u2013295","journal-title":"Updates Surg"},{"issue":"2","key":"2630_CR23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1177\/1553350610392243","volume":"18","author":"O Schwandner","year":"2011","unstructured":"Schwandner O, Brunner M, Dietl O (2011) Quality of life and functional results of submucosal injection therapy using dextranomer hyaluronic acid for fecal incontinence. Surg innov 18(2):130\u2013135","journal-title":"Surg innov"},{"issue":"2","key":"2630_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10151-008-0406-x","volume":"12","author":"E Ganio","year":"2008","unstructured":"Ganio E, Marino F, Giani I et al (2008) Injectable synthetic calcium hydroxylapatite ceramic microspheres (coaptite) for passive fecal incontinence. Tech Coloproctol 12(2):99\u2013102","journal-title":"Tech Coloproctol"},{"issue":"11","key":"2630_CR25","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1007\/s10350-007-9009-2","volume":"50","author":"J Tan","year":"2007","unstructured":"Tan J, Chan M, Tjandra J (2007) Evolving therapy for fecal incontinence. Dis Colon Rectum 50(11):1950\u20131967","journal-title":"Dis Colon Rectum"},{"key":"2630_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-3-319-32226-1_10","volume-title":"Management of fecal incontinence","author":"C Ratto","year":"2016","unstructured":"Ratto C, Parello A, Donisi L, Litta F (2016) Injectable and implantable agents: current evidence and perspective. Management of fecal incontinence. Springer, Berlin, Heidelberg, pp 91\u2013105"},{"issue":"11","key":"2630_CR27","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1002\/bjs.7645","volume":"98","author":"ZI Hussain","year":"2011","unstructured":"Hussain ZI, Lim M, Stojkovic SG (2011) Systematic review of perianal implants in the treatment of faecal incontinence. Br J Surg 98(11):1526\u20131536","journal-title":"Br J Surg"},{"key":"2630_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10151-011-0767-4","volume":"16","author":"A Parello","year":"2012","unstructured":"Parello A (2012) Can gatekeeper, a new bulking agent be equivalent to SNS in patients with fecal incontinence in the presence of only internal sphincter defects. Tech Coloproctol 16:77","journal-title":"Tech Coloproctol"},{"issue":"12","key":"2630_CR29","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s10151-017-1723-8","volume":"21","author":"L Trenti","year":"2017","unstructured":"Trenti L, Biondo S, Noguerales F et al (2017) Outcomes of gatekeeper \u2122 prosthesis implantation for the treatment of fecal incontinence: a multicenter observational study. Tech Coloproctol 21(12):963","journal-title":"Tech Coloproctol"},{"issue":"5","key":"2630_CR30","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/bjs.4997","volume":"92","author":"CJ Vaizey","year":"2005","unstructured":"Vaizey CJ, Kamm MA (2005) Injectable bulking agents for treating faecal incontinence. Br J Surg 92(5):521\u2013527","journal-title":"Br J Surg"},{"issue":"3","key":"2630_CR31","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1177\/1553350618818924","volume":"26","author":"U Grossi","year":"2019","unstructured":"Grossi U, De Simone V, Parello A et al (2019) Gatekeeper improves voluntary contractility in patients with fecal incontinence. Surgical Innovation 26(3):321\u2013327","journal-title":"Surgical Innovation"},{"issue":"3","key":"2630_CR32","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00384-016-2742-z","volume":"32","author":"F de la Portilla","year":"2017","unstructured":"de la Portilla F, Reyes-D\u00edaz M, Maestre M et al (2017) Ultrasonographic evidence of gatekeeper\u2122 prosthesis migration in patients treated for faecal incontinence: a case series. Int J Colorectal Dis 32(3):437\u2013440","journal-title":"Int J Colorectal Dis"},{"key":"2630_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007959.pub3","author":"Y Maeda","year":"2013","unstructured":"Maeda Y, Laurberg S, Norton C, Maeda Y (2013) Perianal injectable bulking agents as treatment for faecal incontinence in adults. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD007959.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2630_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10151-015-1396-0","volume":"20","author":"C Ratto","year":"2016","unstructured":"Ratto C, Donisi L, Litta F, Campenni P, Parello A (2016) Implantation of SphinKeeper\u2122: a new artificial anal sphincter. Tech Coloproctol 20(1):59\u201366","journal-title":"Tech Coloproctol"},{"issue":"5","key":"2630_CR35","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/bjs.11558","volume":"107","author":"F Litta","year":"2020","unstructured":"Litta F, Parello A, De Simone V, Campenn\u00ec P, Orefice R, Marra AA, Goglia M, Moroni R, Ratto C (2020) Efficacy of Sphinkeeper\u2122 implant in treating faecal incontinence. Br J Surg 107(5):484\u2013488","journal-title":"Br J Surg"}],"updated-by":[{"DOI":"10.1007\/s10151-022-02655-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000}}],"container-title":["Techniques in Coloproctology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-022-02630-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10151-022-02630-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-022-02630-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T10:06:26Z","timestamp":1655892386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10151-022-02630-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,20]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["2630"],"URL":"https:\/\/doi.org\/10.1007\/s10151-022-02630-z","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10151-022-02655-4","asserted-by":"object"}]},"ISSN":["1123-6337","1128-045X"],"issn-type":[{"value":"1123-6337","type":"print"},{"value":"1128-045X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,20]]},"assertion":[{"value":"19 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10151-022-02655-4","URL":"https:\/\/doi.org\/10.1007\/s10151-022-02655-4","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest, directly related to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}